Your SlideShare is downloading. ×
0
Ranbaxy Laboratories Ltd Presented by Sudip & Pradipta
Company Highlights  <ul><li>Largest pharmaceutical company  </li></ul><ul><li>FDA inspected and approved facilities.  </li...
Timelines <ul><li>1962:  Ranjit Singh and Gurbux Singh in Amritsar </li></ul><ul><li>1977:  First  JV  Nigeria  </li></ul>...
Internationalization
International Biz <ul><li>USA </li></ul><ul><li>Largest Healthcare market </li></ul><ul><li>Entered in 1995, now the large...
<ul><li>ITALY(GSK) & SPAIN </li></ul><ul><li>Organic opportunities. </li></ul><ul><li>Bought  Allen in Italy </li></ul><ul...
<ul><li>BELGIUM (Ethimed)   </li></ul><ul><li>High priced and profitable market. </li></ul><ul><li>Market is not too large...
<ul><li>ROMANIA (Terapia) </li></ul><ul><li>Low cost market in terms of manufacturing. </li></ul><ul><li>Strategically wel...
Managing the business <ul><ul><li>Created trade support & networks overseas </li></ul></ul><ul><ul><li>Confidence in gener...
Cont… <ul><ul><li>Allowed to diverse into new markets </li></ul></ul><ul><ul><li>Intangible assets </li></ul></ul>
<ul><li>Thank You </li></ul>
Upcoming SlideShare
Loading in...5
×

R A N B A X Yfinal

960

Published on

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
960
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
32
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "R A N B A X Yfinal"

  1. 1. Ranbaxy Laboratories Ltd Presented by Sudip & Pradipta
  2. 2. Company Highlights <ul><li>Largest pharmaceutical company </li></ul><ul><li>FDA inspected and approved facilities. </li></ul><ul><li>Expertise in diverse categories </li></ul><ul><li>Expertise in OTC </li></ul><ul><li>Strengths and vibrancy </li></ul><ul><li>Other Expertise </li></ul>
  3. 3. Timelines <ul><li>1962: Ranjit Singh and Gurbux Singh in Amritsar </li></ul><ul><li>1977: First JV Nigeria </li></ul><ul><li>1987: State-of-the-art API facility in Toansa in preparation for entry </li></ul><ul><li>into the U.S. market, receives FDA approval in 1988 </li></ul><ul><li>1992: Launches a joint marketing agreement with Eli Lilly </li></ul><ul><li>1993: A joint venture is launched in China; a new research-driven </li></ul><ul><li>NCE and NDDS strategy launched </li></ul><ul><li>1995: The company acquires Ohm Laboratories in the United </li></ul><ul><li>States and builds a new FDA-approved production facility </li></ul><ul><li>2000: A cquires Basics, Bayer's generics business in Germany; the </li></ul><ul><li>company enters Brazil </li></ul><ul><li>2003 : Acquires Aventis in France </li></ul><ul><li>Latest : Wish to acquire $2 Billion stake in Merck </li></ul>
  4. 4. Internationalization
  5. 5. International Biz <ul><li>USA </li></ul><ul><li>Largest Healthcare market </li></ul><ul><li>Entered in 1995, now the largest market for the company </li></ul><ul><li>Acquire Ohm labs </li></ul><ul><li>28% of Ranbaxy’s revenues </li></ul><ul><li>96 products approved by FDA </li></ul>
  6. 6. <ul><li>ITALY(GSK) & SPAIN </li></ul><ul><li>Organic opportunities. </li></ul><ul><li>Bought Allen in Italy </li></ul><ul><li>Among top 10 global market. </li></ul><ul><li>Low penetration on generics. </li></ul><ul><li>Patents expiries happen later. </li></ul><ul><li>First movers advantage. </li></ul>
  7. 7. <ul><li>BELGIUM (Ethimed) </li></ul><ul><li>High priced and profitable market. </li></ul><ul><li>Market is not too large. </li></ul><ul><li>Existence of 10-12 products. </li></ul>
  8. 8. <ul><li>ROMANIA (Terapia) </li></ul><ul><li>Low cost market in terms of manufacturing. </li></ul><ul><li>Strategically well positioned. </li></ul><ul><li>Wide marketing authorizations. </li></ul><ul><li>Strong product portfolio. </li></ul><ul><li>Strong field force </li></ul>
  9. 9. Managing the business <ul><ul><li>Created trade support & networks overseas </li></ul></ul><ul><ul><li>Confidence in generic drug business </li></ul></ul><ul><ul><li>Germany 4.8 </li></ul></ul><ul><ul><li>UK 2.8 </li></ul></ul><ul><ul><li>France 1.6 </li></ul></ul><ul><ul><li>Italy 0.5 </li></ul></ul><ul><ul><li>(major size of generics market in $ billion) </li></ul></ul>
  10. 10. Cont… <ul><ul><li>Allowed to diverse into new markets </li></ul></ul><ul><ul><li>Intangible assets </li></ul></ul>
  11. 11. <ul><li>Thank You </li></ul>
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×